Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baptiste Le Calvez

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Expert Opinion on Investigational Drugs|July 13, 2021
Immune checkpoint inhibitors for the treatment of myeloma: novel investigational optionsBaptiste Le Calvez, Philippe Moreau, Cyrille Touzeau
European Journal of Ophthalmology|April 15, 2025
Uveitis in child treated for acute myeloblastic leukemia: Do not overlook poststreptococcal inflammationPhilippe Gardeton, Inés Chabbi, Margaux Camuset, et al.
Biomedicines|February 25, 2023
Two Ways of Targeting a CD19 Positive Relapse of Acute Lymphoblastic Leukaemia after Anti-CD19 CAR-T CellsAudrey Grain, Jocelyn Ollier, Thierry Guillaume, et al.
Bulletin Du Cancer|November 29, 2023
[Can academic structures improve access to CAR-T cells?]Camille Le Guen, Audrey Grain, Baptiste Le Calvez, et al.
Ejhaem|July 18, 2022
Extensive myelitis with eosinophilic meningitis after Chimeric antigen receptor T cells therapyBaptiste Le Calvez, Marion Eveillard, Paul Decamps, et al.
Cancer Innovation|December 21, 2023
Added value of molecular karyotype in childhood acute lymphoblastic leukemiaMargaux Camuset, Baptiste Le Calvez, Olivier Theisen, et al.
Journal for Immunotherapy of Cancer|December 3, 2025
Evaluation of multi-antigen targeting ADCC strategies in pediatric BCP-ALLAudrey Grain, Jocelyn Ollier, Baptiste Le Calvez, et al.
The Lancet. Digital Health|April 26, 2024
Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in FranceVincent Alcazer, Grégoire Le Meur, Marie Roccon, et al.
Ejhaem|July 18, 2022
RAS mutation leading to acquired resistance to dabrafenib and trametinib therapy in a multiple myeloma patient harboring BRAF mutationBaptiste Le Calvez, Yannick Le Bris, Guillaume Herbreteau, et al.
Hemasphere|July 9, 2024
Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation?Baptiste Le Calvez, Maxime Jullien, Jean H Dalle, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|July 13, 2021
Immune checkpoint inhibitors for the treatment of myeloma: novel investigational optionsBaptiste Le Calvez, Philippe Moreau, Cyrille Touzeau
European Journal of Ophthalmology|April 15, 2025
Uveitis in child treated for acute myeloblastic leukemia: Do not overlook poststreptococcal inflammationPhilippe Gardeton, Inés Chabbi, Margaux Camuset, et al.
Biomedicines|February 25, 2023
Two Ways of Targeting a CD19 Positive Relapse of Acute Lymphoblastic Leukaemia after Anti-CD19 CAR-T CellsAudrey Grain, Jocelyn Ollier, Thierry Guillaume, et al.
Bulletin Du Cancer|November 29, 2023
[Can academic structures improve access to CAR-T cells?]Camille Le Guen, Audrey Grain, Baptiste Le Calvez, et al.
Ejhaem|July 18, 2022
Extensive myelitis with eosinophilic meningitis after Chimeric antigen receptor T cells therapyBaptiste Le Calvez, Marion Eveillard, Paul Decamps, et al.
Cancer Innovation|December 21, 2023
Added value of molecular karyotype in childhood acute lymphoblastic leukemiaMargaux Camuset, Baptiste Le Calvez, Olivier Theisen, et al.
Journal for Immunotherapy of Cancer|December 3, 2025
Evaluation of multi-antigen targeting ADCC strategies in pediatric BCP-ALLAudrey Grain, Jocelyn Ollier, Baptiste Le Calvez, et al.
The Lancet. Digital Health|April 26, 2024
Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in FranceVincent Alcazer, Grégoire Le Meur, Marie Roccon, et al.
Ejhaem|July 18, 2022
RAS mutation leading to acquired resistance to dabrafenib and trametinib therapy in a multiple myeloma patient harboring BRAF mutationBaptiste Le Calvez, Yannick Le Bris, Guillaume Herbreteau, et al.
Hemasphere|July 9, 2024
Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation?Baptiste Le Calvez, Maxime Jullien, Jean H Dalle, et al.
Pageof 2